Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8289 | 1270 | 31.9 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
2729 | 2 | THYMOSIN BETA 4//THYMOSIN ALPHA 1//PROTHYMOSIN ALPHA | 3281 |
8289 | 1 | THYMOSIN ALPHA 1//PROTHYMOSIN ALPHA//THYMALFASIN | 1270 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THYMOSIN ALPHA 1 | authKW | 2041155 | 9% | 72% | 118 |
2 | PROTHYMOSIN ALPHA | authKW | 2033563 | 8% | 83% | 102 |
3 | THYMALFASIN | authKW | 433955 | 1% | 95% | 19 |
4 | PROTHYMOSIN | authKW | 336587 | 1% | 100% | 14 |
5 | THYMOPENTIN | authKW | 282936 | 3% | 37% | 32 |
6 | THYMIC PEPTIDES | authKW | 204868 | 1% | 61% | 14 |
7 | THYMOSIN | authKW | 194702 | 2% | 30% | 27 |
8 | PROTHYMOSIN ALPHA 1 | authKW | 192336 | 1% | 100% | 8 |
9 | THYMOSTIMULIN | authKW | 145096 | 1% | 46% | 13 |
10 | SPLENOPENTIN | authKW | 130892 | 1% | 78% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 6332 | 34% | 0% | 437 |
2 | Pharmacology & Pharmacy | 756 | 16% | 0% | 208 |
3 | Biochemistry & Molecular Biology | 742 | 23% | 0% | 298 |
4 | Oncology | 623 | 13% | 0% | 169 |
5 | Cell Biology | 400 | 11% | 0% | 139 |
6 | Medicine, Research & Experimental | 283 | 7% | 0% | 85 |
7 | Biophysics | 197 | 6% | 0% | 71 |
8 | Gastroenterology & Hepatology | 143 | 4% | 0% | 51 |
9 | Chemistry, Medicinal | 124 | 4% | 0% | 47 |
10 | Biochemical Research Methods | 80 | 4% | 0% | 46 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SECT GENES GENE PROD | 120210 | 0% | 100% | 5 |
2 | SEZ FISIOL UMANA FUNZ BIOL INTEGRATE F BOTTAZZI | 34965 | 0% | 36% | 4 |
3 | MOL PHARMACOL NEUROSCI | 34028 | 1% | 8% | 17 |
4 | CLIN UNIT 3 | 32055 | 0% | 67% | 2 |
5 | S NEUROCIENCIA RAMON DOMINGUEZ | 32055 | 0% | 67% | 2 |
6 | AFFILIATED HOSP 1 INFECT DISMINIST PUBL | 24042 | 0% | 100% | 1 |
7 | AREA BIOL PROMUBIE | 24042 | 0% | 100% | 1 |
8 | ARMY HOSP 202 | 24042 | 0% | 100% | 1 |
9 | CNRS UNITE INTERACT MOLEC CELLULAI 041149 | 24042 | 0% | 100% | 1 |
10 | DEPE SCI TECH | 24042 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SURVEY OF IMMUNOLOGIC RESEARCH | 61966 | 2% | 12% | 21 |
2 | THYMUS | 39639 | 2% | 5% | 31 |
3 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 20882 | 3% | 2% | 42 |
4 | CLINICS IN IMMUNOLOGY AND ALLERGY | 7170 | 1% | 4% | 7 |
5 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 6155 | 1% | 2% | 11 |
6 | IMMUNOPHARMACOLOGY | 5199 | 1% | 1% | 17 |
7 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 4917 | 1% | 2% | 10 |
8 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 3422 | 2% | 1% | 25 |
9 | CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 2549 | 1% | 1% | 19 |
10 | VITAMINS AND HORMONES | 2464 | 0% | 2% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYMOSIN ALPHA 1 | 2041155 | 9% | 72% | 118 | Search THYMOSIN+ALPHA+1 | Search THYMOSIN+ALPHA+1 |
2 | PROTHYMOSIN ALPHA | 2033563 | 8% | 83% | 102 | Search PROTHYMOSIN+ALPHA | Search PROTHYMOSIN+ALPHA |
3 | THYMALFASIN | 433955 | 1% | 95% | 19 | Search THYMALFASIN | Search THYMALFASIN |
4 | PROTHYMOSIN | 336587 | 1% | 100% | 14 | Search PROTHYMOSIN | Search PROTHYMOSIN |
5 | THYMOPENTIN | 282936 | 3% | 37% | 32 | Search THYMOPENTIN | Search THYMOPENTIN |
6 | THYMIC PEPTIDES | 204868 | 1% | 61% | 14 | Search THYMIC+PEPTIDES | Search THYMIC+PEPTIDES |
7 | THYMOSIN | 194702 | 2% | 30% | 27 | Search THYMOSIN | Search THYMOSIN |
8 | PROTHYMOSIN ALPHA 1 | 192336 | 1% | 100% | 8 | Search PROTHYMOSIN+ALPHA+1 | Search PROTHYMOSIN+ALPHA+1 |
9 | THYMOSTIMULIN | 145096 | 1% | 46% | 13 | Search THYMOSTIMULIN | Search THYMOSTIMULIN |
10 | SPLENOPENTIN | 130892 | 1% | 78% | 7 | Search SPLENOPENTIN | Search SPLENOPENTIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SAMARA, P , IOANNOU, K , TSITSILONIS, OE , (2016) PROTHYMOSIN ALPHA AND IMMUNE RESPONSES: ARE WE CLOSE TO POTENTIAL CLINICAL APPLICATIONS?.THYMOSINS. VOL. 102. ISSUE . P. 179 -207 | 94 | 86% | 0 |
2 | IOANNOU, K , SAMARA, P , LIVANIOU, E , DERHOVANESSIAN, E , TSITSILONIS, OE , (2012) PROTHYMOSIN ALPHA: A UBIQUITOUS POLYPEPTIDE WITH POTENTIAL USE IN CANCER DIAGNOSIS AND THERAPY.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 61. ISSUE 5. P. 599-614 | 87 | 84% | 14 |
3 | PINEIRO, A , CORDERO, OJ , NOGUEIRA, M , (2000) FIFTEEN YEARS OF PROTHYMOSIN ALPHA: CONTRADICTORY PAST AND NEW HORIZONS.PEPTIDES. VOL. 21. ISSUE 9. P. 1433-1446 | 107 | 90% | 65 |
4 | MOSOIAN, A , (2011) INTRACELLULAR AND EXTRACELLULAR CYTOKINE-LIKE FUNCTIONS OF PROTHYMOSIN ALPHA: IMPLICATIONS FOR THE DEVELOPMENT OF IMMUNOTHERAPIES.FUTURE MEDICINAL CHEMISTRY. VOL. 3. ISSUE 9. P. 1199-1208 | 78 | 73% | 13 |
5 | BEN-EFRAIM, S , KEISARI, Y , OPHIR, R , PECHT, M , TRAININ, N , BURSTEIN, Y , (1999) IMMUNOPOTENTIATING AND IMMUNOTHERAPEUTIC EFFECTS OF THYMIC HORMONES AND FACTORS WITH SPECIAL EMPHASIS ON THYMIC HUMORAL FACTOR THF-GAMMA 2.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 19. ISSUE 4. P. 261 -284 | 103 | 71% | 15 |
6 | KING, R , TUTHILL, C , (2016) IMMUNE MODULATION WITH THYMOSIN ALPHA 1 TREATMENT.THYMOSINS. VOL. 102. ISSUE . P. 151 -178 | 63 | 70% | 0 |
7 | FREIRE, M , SARANDESES, CS , COVELO, G , DIAZ-JULLIEN, C , (2016) PHOSPHORYLATION OF PROTHYMOSIN ALPHA. AN APPROACH TO ITS BIOLOGICAL SIGNIFICANCE.THYMOSINS. VOL. 102. ISSUE . P. 73 -99 | 51 | 82% | 0 |
8 | HANNAPPEL, E , HUFF, T , (2003) THE THYMOSINS - PROTHYMOSIN ALPHA, PARATHYMOSIN, AND BETA-THYMOSINS: STRUCTURE AND FUNCTION.VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 66. VOL. 66. ISSUE . P. 257-296 | 95 | 50% | 60 |
9 | LI, JA , LIU, CH , WANG, FS , (2010) THYMOSIN ALPHA 1 BIOLOGICAL ACTIVITIES, APPLICATIONS AND GENETIC ENGINEERING PRODUCTION.PEPTIDES. VOL. 31. ISSUE 11. P. 2151 -2158 | 50 | 77% | 6 |
10 | GOLDSTEIN, AL , GOLDSTEN, AL , (2009) FROM LAB TO BEDSIDE: EMERGING CLINICAL APPLICATIONS OF THYMOSIN ALPHA(1).EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 9. ISSUE 5. P. 593-608 | 50 | 67% | 41 |
Classes with closest relation at Level 1 |